MAPK pathway inhibitor (Alterome Therapeutics)

N/A

Report date: 2025/06/11 10:42:04
NME

Base Information

Drug NameMAPK pathway inhibitor (Alterome Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionMitogen-activated protein kinase inhibitorsAnticancer protein kinase inhibitors
TargetsMitogen-activated protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlterome Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlterome Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A